Be a part of the Solution

The US Cancer Problem

2+ million

New Cancer Cases

predicted for the year 2025.

2nd

Leading Cause

of deaths in the United States with over 600,000 predicted for 2025.

2.5x

Survivors

more likely to file bankruptcy.

Meet the Community

Member Organizations

Our members drive the success of CancerX, collaborating to set priorities and practices that will help us achieve our mission.

updated member image 9-24-25
CancerX web header (2)

Join This Community

Advisory Leadership

Steering Committee

CancerX’s steering committee provides an additional layer of governance within CancerX’s public-private partnership model.

Xavier Avat
Xavier Avat, MBA, MBE
Chair of Steering Committee - EVP & Chief Business Officer at Moffitt Cancer Center
Jean Chai, MD
Jean Chai, MD
VP, Cancer Service Line NC/GA Division, Advocate Health
Stephen Konya
Stephen Konya
Chief, Innovation and Strategic Partnerships at ONC, U.S. Department of Health and Human Services (HHS).
A Batavia
Ashita S. Batavia, MD, MS
Global Head, Study Innovation,Global Medical Affairs at J&J innovative Medicine
Caroline Chung
Caroline Chung
VP & Chief Data &Analytics Officer, MD Anderson Cancer Center
Amina Ahmed
Amina Ahmed
Director, Rush University Medical Center
Mark Tate
Mark Tate
Executive Director, Oncology Portfolio, Novartis
Grace-CancerX Fellow
Grace Cordovano, PhD, BCPA
CancerX Fellow, Founder & Board Certified Patient Advocate at Enlightening Results
Mellisa Wheeler
Melissa Wheeler
Director Disparities & Outreach, Levine Cancer Institute
Jonathan George-2
Jonathan George
Investor, Flare Capital Partners
Ben Freeberg
Ben Freeberg
Founder and Managing Partner, Oncology Ventures
Baxter Lee
Baxter Lee
President, Clearwater
Craig A. Hunter
Craig A. Hunter
SVP, Oncology & Genetics, Carelon
Ready To Make A Impact?

Become a Member